BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6095580)

  • 1. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.
    Stubbs EB
    Exp Neurol; 2020 Sep; 331():113385. PubMed ID: 32562668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder.
    Figueroa JJ; Bosch EP; Dyck PJ; Singer W; Vrana JA; Theis JD; Dogan A; Klein CJ
    J Peripher Nerv Syst; 2012 Jun; 17(2):182-90. PubMed ID: 22734903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.
    Ariga T
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(7):386-404. PubMed ID: 21785257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5.
    Kashiwamura Y; Sano Y; Abe M; Shimizu F; Haruki H; Maeda T; Kawai M; Kanda T
    Neurochem Res; 2011 May; 36(5):849-55. PubMed ID: 21293925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraproteinemic neuropathies.
    Vital A
    Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy.
    Lach B; Rippstein P; Atack D; Afar DE; Gregor A
    Acta Neuropathol; 1993; 85(3):298-307. PubMed ID: 8384775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].
    Kanda T; Yoshino H; Ariga T; Yamawaki M; Yu RK
    J Cell Biol; 1994 Jul; 126(1):235-46. PubMed ID: 8027181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of peripheral neuropathies.
    Hallett M; Tandon D; Berardelli A
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1193-207. PubMed ID: 3003254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyneuropathy in paraproteinaemia.
    Meier C
    J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathy in IgM lambda paraproteinemia. Immunoreactivity to neural proteins and chondroitin sulfate.
    Yee WC; Hahn AF; Hearn SA; Rupar AR
    Acta Neuropathol; 1989; 78(1):57-64. PubMed ID: 2544072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.
    Vital A; Vital C; Julien J; Baquey A; Steck AJ
    Acta Neuropathol; 1989; 79(2):160-7. PubMed ID: 2480693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein.
    Steck AJ; Murray N; Justafre JC; Meier C; Toyka KV; Heininger K; Stoll G
    J Neurol Neurosurg Psychiatry; 1985 Sep; 48(9):927-9. PubMed ID: 2413173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy.
    Ernerudh JH; Vrethem M; Andersen O; Lindberg C; Berlin G
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):930-4. PubMed ID: 1279127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.
    Meier C; Roberts K; Steck A; Hess C; Miloni E; Tschopp L
    Acta Neuropathol; 1984; 64(4):297-307. PubMed ID: 6095580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waldenström's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium.
    Vital C; Deminière C; Bourgouin B; Lagueny A; David B; Loiseau P
    Neurology; 1985 Apr; 35(4):603-6. PubMed ID: 2984603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyneuropathy in Waldenström's macroglobulinaemia. Passive transfer from man to mouse.
    Hoppe U; Dräger HS; Patzold U; Stark E; Wurster U; Deicher H
    Acta Neurol Scand; 1987 Feb; 75(2):112-6. PubMed ID: 3033974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies.
    Dalakas MC; Flaum MA; Rick M; Engel WK; Gralnick HR
    Neurology; 1983 Nov; 33(11):1406-10. PubMed ID: 6314179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropathy in Waldenstrom's macroglobulinemia].
    Coimbra J; Costa AP; Pita F; Rosado P; de Almeida LB
    Acta Med Port; 1995 Apr; 8(4):253-7. PubMed ID: 7625222
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.